Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus

Research in Veterinary Science

Volumn 89, Issue 2, 2010, Pages 295-300

  Jeoung, Hye Young ^a,b   Lee, Won Ha ^b   Jeong, Wooseog ^a   Ko, Young Joon ^a   Choi, Cheong Up ^a   An, Dong Jun ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

DNA vaccine; EMCV; Virus like particle

Indexed keywords

3C PROTEASE; CAPSID PROTEIN; DNA VACCINE; ENCEPHALOMYOCARDITIS VIRUS VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; NEUTRALIZING ANTIBODY; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 2A; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; ENCEPHALOMYOCARDITIS VIRUS; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION PREVENTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SWINE; TH1 CELL; TH2 CELL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS LIKE AGENT; VIRUS STRAIN; WILD TYPE;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CYTOKINES; DNA, VIRAL; ENCEPHALOMYOCARDITIS VIRUS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; MICE, INBRED BALB C; SWINE; VACCINES, DNA; VIRAL VACCINES;

ENCEPHALOMYOCARDITIS VIRUS; MIRIDAE; MURINAE; MUS; PORCINE ENCEPHALOMYOCARDITIS VIRUS; SUIDAE;

EID: 77955926342     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.03.012     Document Type: Article

References (34)

1. Abrams C.C., King A.M.Q., Belsham G. Assembly of foot-and-mouth disease virus empty capsids synthesized by vaccinia virus expression system. J. Gen. Virol. 1995, 76:3089-3098.
2. Ansardi D.C., Porter D.C., Morrow C.D. Coinfection with recombinant vaccinia virus expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J. Virol. 1995, 65:2088-2092.
3. Avramidis N., Victoratos P., Yiangou M., Hadjipetrou-Kourounakis L. Adjuvant regulation of cytokine profile and antibody isotype of immune response to Mycoplasma agalactiae in mice. Vet. Microbiol. 2002, 88:325-338.
4. Ball J.M., Graham D.Y., Opekun A.R., Gilger M.A., Guerrero R.A., Estes M.K. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 1999, 117:40-48.
5. Beard C., Ward G., Rieder E., Chinsangaram J., Grubman M.J., Mason P.W. Development of DNA vaccines for foot-and-mouth diseases, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 1999, 73:243-249.
6. Beatrice N.J., Agathe O., Lionel P., Pierre P., Evenlyne K. Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune response. Vaccine 2004, 22:1079-1086.
7. Bellier B., Dalba C., Clerc B., Desjardins D., Drury R., Cosset F., Collins M., Klatzmann D. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine 2006, 24:2643-2655.
8. Bellier B., Huret C., Miyalou M., Desjardins D., Frenkiel M., Despres P., Tangy F., Dalba C., Klatzmann D. DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine 2009, 27:5772-5780.
9. Cao Y., Lu Z., Sun J., Bai X., Sun P., Bao H., Chen Y., Guo J., Li D., Liu X., Liu Z. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guiea pigs. Vet. Micorbiol. 2009, 137:10-17.
10. Chen Z., Guo X., Ge X., Jia H., Yang H. Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus. Vaccine 2008, 26:573-580.
11. Chung Y.C., Ho M.S., Wu J.C., Chen W.J., Huang J.H., Chou S.T., Hu Y.C. Immunization with virus like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
12. Donnelly J.J., Ulmer J.B., Liu M.A. DNA vaccine. Dev. Biol. Stand. 1998, 95:43-53.
13. Fromantin C., Jamot B., Cohen J., Piroth L., Pothier P., Kohli E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin induce a Th1/Th2-like immune response. J. Virol. 2001, 75:11010-11016.
14. Hu Y.C., Hsu J.T., Huang J.H., Ho M.S., Ho Y.C. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol. Lett. 2003, 25:919-925.
15. Hunter P., Swanepoel S.P., Esterhuysen J.J., Raath J.P., Bengis R.G., Van der Lugt J.J. The efficacy of an experimental oil-adjuvanted encephalomyocarditis virus vaccine in elephants, mice and pigs. Vaccine 1998, 16:291-296.
16. Jin H., Xiao W., Xiao C., Yu Y., Kang Y., Du X., Wei X., Wang B. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles. Viral Immunol. 2007, 20:429-440.
17. Ko Y.J., Choi K.S., Nah J.J., Paton D.J., Oem J.K., Wilsden G., Kang S.H., Jo N.I., Lee J.H., Kim J.H., Lee H.W., Park J.M. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay. Clin. Diagn Lab. Immun. 2005, 12:922-929.
18. Krausslich H.G., Holscher C., Reuer Q., Harber J., Wimmer E. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and viral infectivity. J. Virol. 1990, 64:2433-2436.
19. Liu M.A., Fu T.M., Donnelly J.J., Caulfield M.J., Ulmer J.B. DNA vaccines. Mechanisms for generation of immune responses. Adv. Exp. Med. Biol. 1998, 452:187-191.
20. McLelland D.J., Kirkland P.D., Rose K.A., Dixon R.J., Simth N. Serologic responses of Barbary sheep (Ammotragus lervia), Indian antelope (Antilope cervicapara), wallaroos (Macropus robustus), and chimpanzees (Pan troglodytes) to an inactivated encephalomyocarditis virus vaccine. J. Zoo Wildl. Med. 2005, 36:69-73.
21. Murnane T.G., Craighead J.E., Mondragon H., Shelokov A. Fatal disease of swine due to encephalomyocarditis virus. Science 1960, 131:498-499.
22. Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol. 2003, 11:438-444.
23. Osorio J.E., Hubbard G.B., Soike K.F., Girard M., van der Werf S., Moulin J.C. Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus. Vaccine 1997, 15:1827-1833.
24. Paliard X., Liu Y., Wagner R., Wolf H., Baenziger J., Walker C.M. Priming of strong, broad, and long lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of administration of a virus-like particle vaccine in rhesus macaques. AIDS Res. Hum. Retroviruses 2000, 16:273-282.
25. Palmenberg A.C., Kirby E.M., Janda M.R., Drake N.L., Duke G.M., Potratz K.F., Collett M.S. The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region. Nucleic Acids Res. 1984, 12:2969-2984.
26. Pinto L.A., Castle P.E., Roden R.B., Harro C.D., Lowy D.R., Schiller J.T., Wallace D., Williams M., Frazer I.H., Berzofsky J.A., Hildesheim A. HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine 2005, 23:3555-3564.
27. Robinson H.L., Pertmer T.M. DNA vaccines for viral infections: basic studies and applications. Adv. Virus Res. 2000, 55:1-74.
28. Rueda P., Martinez-Torrecuadrada J.L., Sarraseca J., Sedlik C., del Barrio M., Hurtado A., Leclerc C., Casal J.I. Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses. Vaccine 1999, 18:325-332.
29. Sanz-Parra A., Blasco R., Sobrino F., Ley V. Analysis of the B and T cell response in Guinea pig induced with recombinant vaccine expressing foot and mouth disease virus structural proteins. Arch. Virol. 1998, 143:389-398.
30. Schirmbeck R., Bohm W., Reimann J. Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology 1996, 39:111-119.
31. Szécsi J., Gabriel G., Edfeldt G., Michelet M., Klenk H.D., Cosset F. DNA vaccination with single-plasmid construct coding for virus like particles protects mice against infection with a highly pathogenic avian influenza A virus. J. Infect. Dis. 2009, 200:181-190.
32. Victoratos P., Yiangou M., Avramidis N., Handjipetrou L. Regulation of cytokine gene expression by adjuvants in vivo. Clin. Exp. Immunol. 1997, 109:569-578.
33. Yao Q., Bu Z., Vzorov A., Yang C., Compans R.W. Virus-like particle and DNA-based candidate AIDS vaccines. Vaccine 2003, 21:638-6343.
34. Young K.R., Smith J.M., Ross T.M. Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle. Virology 2004, 327:262-272.